Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Cell Biochem ; 119(9): 7218-7225, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29761869

RESUMO

Growing evidences suggested that microRNAs (miRNAs) played important roles in the development of intervertebral disc degeneration (IDD). However, the expression level and function of miR-665 in IDD remain unknown. In this study, we showed that the expression level of miR-665 was upregulated in degenerative human NP samples. In addition, miR-665 expression level gradually increased with the exacerbation of disc degeneration grade. Moreover, miR-665 expression level was positively associated with the Pfirrmann grade. Ectopic expression of miR-665 promoted NP cell growth. Furthermore, miR-665 overexpression decreased aggrecan and Col II expression and ectopic expression of miR-665 increased MMP-3 and MMP-13 expression in NP cell. We identified growth differentiation factor 5 (GDF5) was a direct target gene of miR-665 in NP cell and enforced expression of miR-665 decreased GDF5 expression. Elevated expression of miR-665 enhanced NP cell proliferation and decreased aggrecan and Col II expression. In addition, ectopic expression of miR-665 increased MMP-3 and MMP-13 expression through inhibiting GDF5 expression in NP cells. These results suggested that dysregulated miR-665 expression might act an important role in the development of IDD.


Assuntos
Proliferação de Células/efeitos dos fármacos , Matriz Extracelular/metabolismo , Fator 5 de Diferenciação de Crescimento/metabolismo , Degeneração do Disco Intervertebral/metabolismo , MicroRNAs/genética , MicroRNAs/metabolismo , Núcleo Pulposo/metabolismo , Agrecanas/antagonistas & inibidores , Agrecanas/metabolismo , Análise de Variância , Células Cultivadas , Expressão Ectópica do Gene , Fator 5 de Diferenciação de Crescimento/antagonistas & inibidores , Humanos , Disco Intervertebral/metabolismo , Metaloproteinase 13 da Matriz/metabolismo , Metaloproteinase 3 da Matriz/metabolismo , Mimetismo Molecular , Transfecção , Regulação para Cima
2.
Biochem Biophys Res Commun ; 488(3): 554-561, 2017 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-28526405

RESUMO

Although hypoxia-inducible factor-lα (HIF-lα) has been reported to have an important role in the metabolism and synthesis of the extracellular matrix (ECM) of nucleus pulposus cells (NPCs), the underlying mechanism has not been fully clarified. Here, we show for the first time that NOTCH1 expression is decreased in NPs isolated from degenerated human intervertebral discs (IVDs), as well as in the NPs of NP-specific HIF-1α-/- mice. Our study reveals that overexpression of HIF-1α leads to increased expression of NOTCH1, the NOTCH1 ligand JAGGED1, and its target gene hairy and enhancer of split-1 (HES1), while also upregulating collagen Π and aggrecan expression in human NPCs. Importantly, these changes in expression are significantly suppressed by the NOTCH1 inhibitor DAPT. In parallel with changes in collagen Π and aggrecan expression, inhibition of the HIF-1α-NOTCH1 pathway altered ECM turnover by suppressing expression of the matrix metalloproteinases MMP1 and MMP13, while increasing the expression of tissue inhibitor of metalloproteinase-1 (TIMP1). Lastly, activation of NOTCH1 via JAGGED1 in human NPCs isolated from degenerated IVDs restored collagen Π and aggrecan expression. Therefore, our study shows that HIF-1α regulates collagen Π and aggrecan expression through NOTCH1 signaling and implicate NOTCH1 as a potential therapeutic target in disc degeneration.


Assuntos
Agrecanas/metabolismo , Colágeno Tipo II/metabolismo , Subunidade alfa do Fator 1 Induzível por Hipóxia/metabolismo , Degeneração do Disco Intervertebral/metabolismo , Núcleo Pulposo/metabolismo , Receptor Notch1/metabolismo , Transdução de Sinais , Adolescente , Adulto , Idoso , Agrecanas/antagonistas & inibidores , Agrecanas/genética , Animais , Células Cultivadas , Colágeno Tipo II/antagonistas & inibidores , Colágeno Tipo II/genética , Diaminas/farmacologia , Relação Dose-Resposta a Droga , Feminino , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/antagonistas & inibidores , Subunidade alfa do Fator 1 Induzível por Hipóxia/deficiência , Subunidade alfa do Fator 1 Induzível por Hipóxia/genética , Masculino , Camundongos , Camundongos Knockout , Pessoa de Meia-Idade , Núcleo Pulposo/citologia , Núcleo Pulposo/efeitos dos fármacos , Receptor Notch1/antagonistas & inibidores , Receptor Notch1/genética , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Relação Estrutura-Atividade , Tiazóis/farmacologia , Adulto Jovem
3.
Biochem Biophys Res Commun ; 379(4): 914-9, 2009 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-19138670

RESUMO

Synovial chondromatosis is characterized by the formation of osteocartilaginous nodules (free bodies) under the surface of the synovial membrane in joints. Free bodies and synovium isolated from synovial chondromatosis patients expressed high levels of BMP-2 and BMP-4 mRNAs. BMP-2 stimulated the expression of Sox9, Col2a1, and Aggrecan mRNAs in free-body and synovial cells and that of Runx2, Col1a1, and Osteocalcin mRNAs in the synovial [corrected] cells only. BMP-2 increased the number of alcian blue-positive colonies in the free-body cell culture but not in the synovial cell culture. Noggin suppressed the expression of Sox9, Col2a1, Aggrecan, and Runx2 mRNAs in both the free-body and synovial cells. Further, it inhibited Osteocalcin expression in the synovial cells. These results suggest that BMPs are involved in the pathobiology of cartilaginous and osteogenic metaplasia observed in synovial chondromatosis.


Assuntos
Proteínas Morfogenéticas Ósseas/metabolismo , Condromatose Sinovial/metabolismo , Condromatose Sinovial/patologia , Agrecanas/antagonistas & inibidores , Agrecanas/biossíntese , Proteína Morfogenética Óssea 2/farmacologia , Proteínas Morfogenéticas Ósseas/antagonistas & inibidores , Proteínas Morfogenéticas Ósseas/farmacologia , Proteínas de Transporte/farmacologia , Cartilagem Articular/efeitos dos fármacos , Cartilagem Articular/metabolismo , Cartilagem Articular/patologia , Células Cultivadas , Colágeno Tipo II/antagonistas & inibidores , Colágeno Tipo II/biossíntese , Subunidade alfa 1 de Fator de Ligação ao Core/antagonistas & inibidores , Subunidade alfa 1 de Fator de Ligação ao Core/biossíntese , Humanos , Osteocalcina/antagonistas & inibidores , Osteocalcina/biossíntese , Proteínas Recombinantes/farmacologia , Fatores de Transcrição SOX9/antagonistas & inibidores , Fatores de Transcrição SOX9/biossíntese , Fator de Crescimento Transformador beta/farmacologia
4.
Tissue Eng ; 13(1): 101-10, 2007 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17518584

RESUMO

The temporomandibular joint (TMJ) disc is maintained by a population of fibrochondrocytes. Although articular chondrocytes exhibit zonal differences and de-differentiate in monolayer culture, such variations are unknown for fibrochondrocytic populations. This study's objective was to define topographical cellular variations in the porcine TMJ disc and investigate changes in the disc's gene expression levels over multiple passages using quantitative reverse transcriptase polymerase chain reaction. For topographical characterization, samples were acquired from posterior, anterior, lateral, medial, and intermediate zone sections and subdivided into inferior and superior halves. For passage characterization, cells were plated and passaged for 35 days, with samples acquired at every passage. The medial region had the lowest expression of genes indicative of fibroblastic activity, but in general, topographical variations were limited. Passage effects were evident; gene expression levels of aggrecan, collagen type I, and collagen type II dropped 20%, 23%, and 73% per passage, respectively. In contrast, decorin and glyseraldehyde-3-phosphate dehydrogenase gene expression increased 33% and 27% per passage, respectively. These data indicate that TMJ disc cells undergo significant changes due to monolayer expansion, experiencing losses in major chondrocytic markers (aggrecan and collagen type II) and fibroblastic markers (collagen type I) and posing a serious impediment to studies in which cell passaging is required.


Assuntos
Proteínas da Matriz Extracelular/biossíntese , Proteínas da Matriz Extracelular/genética , Perfilação da Expressão Gênica , Disco da Articulação Temporomandibular/citologia , Disco da Articulação Temporomandibular/metabolismo , Agrecanas/antagonistas & inibidores , Agrecanas/biossíntese , Agrecanas/genética , Animais , Técnicas de Cultura de Células , Divisão Celular/genética , Células Cultivadas , Colágeno Tipo I/antagonistas & inibidores , Colágeno Tipo I/biossíntese , Colágeno Tipo I/genética , Colágeno Tipo II/antagonistas & inibidores , Colágeno Tipo II/biossíntese , Colágeno Tipo II/genética , Proteínas da Matriz Extracelular/antagonistas & inibidores , Feminino , Suínos , Disco da Articulação Temporomandibular/enzimologia , Fatores de Tempo
5.
Stem Cell Rev Rep ; 9(2): 132-9, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23135703

RESUMO

The purpose with this study was to investigate the effect of phenol red (PR) on chondrogenic and osteogenic differentiation of human mesenchymal stem cells (hMSCs). hMSCs were differentiated into chondrogenic and osteogenic directions in DMEM with and without PR for 2, 7, 14, 21, and 28 days. Gene expression of chondrogenic and osteogenic markers were analyzed by RT-qPCR. The presence of proteoglycans was visualized histologically. Osteogenic matrix deposition and mineralization were examined measuring the alkaline phophatase activity and calcium deposition. During chondrogenic differentiation PR decreased sox9, collagen type 2, aggrecan on day 14 and 21 (P < 0.05), and proteoglycan synthesis on day 21 and 28. Collagen type 10 was decreased on day 21 (P < 0.05). During osteogenic differentiation PR increased alkaline phosphatase on day 7 while decreased on day 21 (P < 0.05). PR increased collagen type 1 on day 7, 14, and day 21 (P < 0.05). The alkaline phosphatase activity was increased after 2, 7, and 14 days (P < 0.05). The deposition of calcium was decreased on day 21 (P < 0.05). Our results indicate that PR should be removed from the culture media when differentiating hMSCs into chondrogenic and osteogenic directions due to the effects on these differentiation pathways.


Assuntos
Condrócitos/efeitos dos fármacos , Meios de Cultura/farmacologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Osteócitos/efeitos dos fármacos , Fenolsulfonaftaleína/farmacologia , Agrecanas/antagonistas & inibidores , Agrecanas/genética , Agrecanas/metabolismo , Fosfatase Alcalina/metabolismo , Cálcio/metabolismo , Diferenciação Celular , Células Cultivadas , Condrócitos/citologia , Condrócitos/metabolismo , Colágeno Tipo II/antagonistas & inibidores , Colágeno Tipo II/genética , Colágeno Tipo II/metabolismo , Colágeno Tipo X/antagonistas & inibidores , Colágeno Tipo X/genética , Colágeno Tipo X/metabolismo , Meios de Cultura/química , Expressão Gênica/efeitos dos fármacos , Humanos , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Osteócitos/citologia , Osteócitos/metabolismo , Proteoglicanas/biossíntese , Fatores de Transcrição SOX9/antagonistas & inibidores , Fatores de Transcrição SOX9/genética , Fatores de Transcrição SOX9/metabolismo , Adulto Jovem
6.
J Orthop Res ; 28(3): 379-83, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19780199

RESUMO

Nucleus pulposus (NP) cells, sourced from herniation surgeries, may be used as a cell-based therapy for intervertebral disc (IVD) degeneration. But, both the regenerative potential of these degenerative adult NP cells and how to stimulate optimum matrix synthesis is not yet clear. The purpose of the current study was to understand the different phenotypic behaviors between degenerative adult NP cells and normal adolescent NP cells. Degenerative adult NP cells produced a significantly higher amount of proteoglycans and collagens than adolescent cells. Insulin-like growth factor-1 was the only anabolic cytokine with increased endogenous expression in degenerative adult NP cells. TGF-beta1 treatment of degenerative NP cells promoted matrix synthesis but stimulated too much type I collagen and suppressed type II collagen and aggrecan. Adult degenerative NP cells possess upregulated regenerative potential, but stimulation in addition to TGF-beta1 is needed to enhance matrix productivity and optimize the collagen expression profile.


Assuntos
Envelhecimento , Degeneração do Disco Intervertebral/etiologia , Degeneração do Disco Intervertebral/fisiopatologia , Regeneração , Adolescente , Adulto , Agrecanas/antagonistas & inibidores , Proliferação de Células , Colágeno/biossíntese , Colágeno Tipo I/biossíntese , Colágeno Tipo II/antagonistas & inibidores , Citocinas/metabolismo , Matriz Extracelular/metabolismo , Humanos , Fator de Crescimento Insulin-Like I/metabolismo , Degeneração do Disco Intervertebral/patologia , Proteoglicanas/biossíntese , Fator de Crescimento Transformador beta1/farmacologia , Regulação para Cima , Adulto Jovem
7.
Osteoarthritis Cartilage ; 16(3): 373-84, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17707661

RESUMO

OBJECTIVE: Avocado-Soybean Unsaponifiables (ASU) represent one of the most commonly used drugs for symptomatic osteoarthritis (OA). The mechanisms of its activities are still poorly understood. We investigate here the effects of ASU on signaling pathways in mouse or human chondrocytes. METHODS: Mouse or human chondrocytes stimulated with interleukin-1beta (IL1beta, 10 ng/ml) and cartilage submitted to a compressive mechanical stress (MS) were studied in the presence or absence of ASU (10 microg/ml). Nuclear factor kappaB (NF-kappaB) activation was assessed by immunoblot, using an I-kappa B alpha antibody, nuclear translocation of NF-kappaB using p65 antibody, and extra-cellular signal-regulated kinase (ERK)1/2 activation using phospho and ERK1/2 antibodies. The binding of the p50/p65 complex on DNA was studied by electrophoretic mobility shift assay. RESULTS: ASU decrease matrix metalloproteinases-3 and -13 expressions and Prostaglandin E(2) (PGE(2)) release in our model. The degradation of I-kappa B alpha is prevented in the presence of ASU as shown by the persistent expression of I-kappa B alpha protein in the cytosol when chondrocytes are stimulated by IL1beta or MS. Nuclear translocation of the NF-kappaB complex is shown by the decrease of the p65 protein from the cytosol, whereas p65 appears in the nucleus under IL1beta stimulation. This translocation is abolished in the presence of ASU. Moreover, bandshift experiments show an inhibition of the IL1beta-induced binding of p50/p65 complexes to NF-kappaB responsive elements in response to ASU. Finally, among the different mitogen-activated protein kinases known to be induced by IL1beta, ERK1/2 was the sole kinase inhibited by ASU. CONCLUSION: These results demonstrate that ASU express a unique range of activities, which could counteract deleterious processes involved in OA, such as inflammation.


Assuntos
Glycine max , NF-kappa B/fisiologia , Osteoartrite/tratamento farmacológico , Persea , Extratos Vegetais/farmacologia , Transdução de Sinais/efeitos dos fármacos , Agrecanas/antagonistas & inibidores , Animais , Western Blotting/métodos , Cartilagem Articular/patologia , Técnicas de Cultura de Células , Condrócitos , Colágeno Tipo II/antagonistas & inibidores , Dinoprostona/metabolismo , Humanos , Cartilagem Hialina , Imunoeletroforese/métodos , Interleucina-1beta/fisiologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Camundongos , Osteoartrite/patologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Estresse Mecânico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA